Certified by Founder Lodge
SR One Capital Management
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to
| Company | Date | Round | Raised |
|---|---|---|---|
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
